NDC 60687-305

Aspirin and Extended-Release Dipyridamole

Aspirin And Extended-release Dipyridamole

Aspirin and Extended-Release Dipyridamole is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Aspirin; Dipyridamole.

Product ID60687-305_809cab53-3d29-b85b-e053-2991aa0af224
NDC60687-305
Product TypeHuman Prescription Drug
Proprietary NameAspirin and Extended-Release Dipyridamole
Generic NameAspirin And Extended-release Dipyridamole
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-10-20
Marketing End Date2019-11-30
Marketing CategoryANDA / ANDA
Application NumberANDA206392
Labeler NameAmerican Health Packaging
Substance NameASPIRIN; DIPYRIDAMOLE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesPlatelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN

Packaging

NDC 60687-305-32

20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-305-32) > 1 CAPSULE in 1 BLISTER PACK (60687-305-33)
Marketing Start Date2017-10-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60687-305-32 [60687030532]

Aspirin and Extended-Release Dipyridamole CAPSULE
Marketing CategoryANDA
Application NumberANDA206392
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-10-20
Marketing End Date2019-11-30

NDC 60687-305-33 [60687030533]

Aspirin and Extended-Release Dipyridamole CAPSULE
Marketing CategoryANDA
Application NumberANDA206392
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-10-20
Marketing End Date2019-11-30

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN25 mg/1

OpenFDA Data

SPL SET ID:423dfd08-1e1b-43f7-ab83-166ec6111608
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 259081
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Decreased Platelet Aggregation [PE]
    • Platelet Aggregation Inhibitor [EPC]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]

    Medicade Reported Pricing

    60687030533 ASPIRIN-DIPYRIDAM ER 25-200 MG

    Pricing Unit: EA | Drug Type:

    60687030532 ASPIRIN-DIPYRIDAM ER 25-200 MG

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Aspirin and Extended-Release Dipyridamole" or generic name "Aspirin And Extended-release Dipyridamole"

    NDCBrand NameGeneric Name
    42291-116Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    42571-274ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLEASPIRIN and Extended-Release DIPYRIDAMOLE
    51407-271Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    60687-305Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    62175-330Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    62559-850Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    65162-596Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.